- To serve as an important medium for the publication of original research in the field of medical science and health research, thus filling gaps in health knowledge for effective utilization of research findings
- To impart current medical knowledge and updated scientific information obtained from research to health professionals for better and appropriate health care management
- To disseminate recent basic, applied and social research findings among health personnel of different strata for enhancing worldwide health development
Archives 2018
Myanmar Health Sciences Research Journal
Volume 30, Number 3
TITLE: Compliance of Service Providers from Private and NGO Sectors in Prescribing Primaquine according to National Anti-malarial Treatment Guideline in Selected Townships in Myanmar
AUTHOR: Myo Kyaw Lwin, Kyaw Zay Ya, Su Yee Mon, Wai Hlaing Soe, Sai San Moon Lu & Aung Thi
SOURCE: Myanmar Health Sciences Research Journal, Vol. 30, No. 3, 2018
ABSTRACT: Primaquine (PQ) has been part of anti-malarial treatment (AMT) for both Plasmodium falciparum and Plasmodium vivax recommended by National Malaria Control Program. The study aimed to estimate the extent
of compliance of service providers with national treatment guideline
in prescribing PQ and to identify the factors associated with service
provider compliance. Cross-sectional descriptive study was designed
using a pretested structured questionnaire and observation of patient registers in past 3 months through face-to-face interview. All health
care providers such as general practitioners, medical doctor, nurses, microscopists and trained volunteers from 7 INGOs working with support of the Global Fund, from randomly selected 111 villages and 21 wards across eight townships in six states and regions were interviewed. Total of 143 participants comprising 71% trained volunteers, 19% general practitioners and 10% other health staff participated in the study. Median service years of service providers was 4.2 and mean was 7.2±8.9. 3% out of 143 respondents prescribed incorrect dosage of PQ as part of Plasmodium falciparum treatment, 1% prescribed incorrect dosage of PQ as part of Plasmodium vivax treatment, 11% of them did not prescribe PQ as part of antimalarial treatment though they should do according to National Anti-Malaria Treatment Guideline (NAMTG). On the other hand, 87% of them found out to be complied with NAMTG in term of dosage, timing and considering contraindication. Service providers with high knowledge score were 2.9 (95% CI: 1.04-8.14) times more likely to comply with NAMTG than those with lower knowledge score (p=0.037). Similarly, majority of respondents 72% mentioned knowledge of the rationale of giving PQ as the promoting factor for them to prescribe it. This highlighted promoting service provider’s knowledge level, particularly rationale of use of PQ as part of AMT is essential for their compliance with NAMTG.
SUBJECT HEADINGS: Primaquine treatment, Compliance, Service provider, Malaria, National guideline, Myanmar
FULL TEXT:
